Skip to main content
. 2022 Sep 8;60(1):1690–1700. doi: 10.1080/13880209.2022.2112239

Figure 1.

Figure 1.

Effects of kirenol on mesangial cells (A) and podocytes (B) were tested by MTT, the dosage range of 0.625–80 μM kirenol did not remarkably inhibit the growth of mesangial cells and podocytes. The dose-response effects of kirenol on the expression of FN and Col IV were detected by Western blot (C) and (D) the corresponding relative expression of FN and Col IV calculated by Image J. Data are expressed as mean ± SEM. *p < 0.05, compared with the normal control group; #p < 0.05, compared with the HG treated group.